TELADOC HEALTH, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $1.47M, a 12.43% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $1.57M, a 30.50% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $1.67M, a 46.94% decline year-over-year.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $3.24M, a 40.08% decline from fiscal 2024.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $5.41M, a 48.19% decline from fiscal 2023.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $10.44M, a 47.79% increase from fiscal 2022.
- TELADOC HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $7.06M, a 53.92% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $1.47M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.24M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.67M 10-Q · filed 2026-07-30 | $3.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $5.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.41M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $3.15M 10-Q · filed 2025-07-30 | |
| 2023-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.44M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $5.79M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $7.06M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | |
| 2022-06-30 | $4.22M 10-Q · filed 2023-07-28 | |
| 2021-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $15.33M 10-K · filed 2024-02-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | |
| 2021-06-30 | $10.54M 10-Q · filed 2022-08-03 | |
| 2020-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.72M 10-K · filed 2023-03-01 |
| 2020-06-30 | $2.47M 10-Q · filed 2021-08-02 | |
| 2019-12-31 | $3.38M 10-K · filed 2022-02-28 | |
| 2019-06-30 | $1.88M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $2.56M 10-K · filed 2021-03-01 | |
| 2018-06-30 | $1.42M 10-Q · filed 2019-10-30 | |
| 2017-12-31 | $888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.15M 10-K · filed 2020-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |